JO
ONC

John Overdeck’s BeOne Medicines Ltd ONC Stock Holding History

John Overdeck’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.7M Buy
286,552
+253,009
+754% +$74.6M 0.06% 373
2026
Q1 		$9.96M Buy
33,543
+25,143
+299% +$8.14M 0.01% 1413
2025
Q4 		$2.55M Buy
+8,400
New +$2.75M ﹤0.01% 2265
2025
Q2 		– Sell
-104,466
Closed -$28.4M – 3639
2025
Q1 		$28.4M Buy
+104,466
New +$24.4M 0.06% 372

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

John Overdeck's ONC Position: Q2 2026 in Review

John Overdeck increased its BeOne Medicines Ltd (ONC) stake by 754% in Q2 2026, buying an estimated $74.6M and bringing the position to 286,552 shares worth $81.7M. The position accounts for 0.06% of the portfolio, ranked #373.

John Overdeck first reported a position in ONC in Q1 2025 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • John Overdeck held 286,552 shares of BeOne Medicines Ltd worth $81.7M as of Q2 2026.
  • John Overdeck bought 253,009 BeOne Medicines Ltd shares in Q2 2026, an estimated $74.6M.
  • BeOne Medicines Ltd made up 0.06% of John Overdeck's portfolio in Q2 2026, its #373 holding.
  • John Overdeck first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 4 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.